CAS: 152460-08-7; 1-(2-Methyl-5-Nitrophenyl)Guanidine Nitrate

该化合物是一种化学化合物,其特点是配以替代苯环的固氨功能组,该化合物通常具有与guanidine和硝基苯球有关的特性,包括由于guanidine组和硝基苯组的潜在基本性,并有可能影响其反应性和稳定性的硝基化合物;硝基苯组往往具有爆炸性,使这种化合物在高能材料领域引起兴趣;此外,苯基环上的甲基替代可影响化合物的溶性以及与其他物质的相互作用;在安全方面,含有硝基化合物的化合物可能对热和冲击敏感,需要小心处理和储存;

结构式图片

相似化合物

77252-56-3 152460-07-6 581076-64-4

欧盟法规

C&L通报REACH预注册

上下游产品

CYANAMID 2-methyl-5-nitroaniline nitric acid o-toluidineo-toluidine 3STLL3 imatinib mesylate 696SKI696 STI-OH

合成工艺路线路线简述

    📜2-氨基-4-硝基甲苯 反应生成(2-甲基-5-硝基苯基)胍硝酸盐
    参考文献:Pyrimidine Derivatives And Processes For The Preparation Thereof
    标题:Pyrimidine Derivatives And Processes For The Preparation Thereof
    摘要:描述了公式i的n-苯基-2-嘧啶胺衍生物,其中r.Sub.1是4-吡啶基,1-甲基-1H-吡咯基,氨基或氨基-低碳基取代的苯基,其中每种情况下的氨基基团是自由的,烷基化或酰基化的,1H-吲哚基或1H-咪唑基与五元环碳原子键合,或未取代或取代的环碳原子上键合未取代或取代的吡啶基,并在氮原子上未取代或取代为氧原子的情况下.R.Sup.2,R.Sup.3,R.Sup.9,X,Y,N和r.Sup.10在权利要求1中定义.这些化合物可以用于肿瘤疾病的治疗等方面.

    海关参考信息

    专利信息


    专利号:US-2011097268-A1
    优先权日:2006-08-23
    标 题 :Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers
    发明人:BORNMANN WILLIAM; ALAUDDIN MIAN; GELOVANI JURI; GHOSH PRADIP; GUO LIWEI; HAN DONGMEI; MAXWELL DAVID; MUKHOPADHYAY UDAY; PENG ZHENGHONG; SHAVRIN ALEKSANDR; YING YUNMING
    权利人:UNIV TEXAS
    摘要:We disclose methods of synthesizing radiohalidated organic compounds and their use in positron emission tomography (PET) imaging of cancer cells.

    专利号:EP-3333162-A1
    优先权日:2016-12-12
    标题 :Metod for preparing n-(2-methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine
    发明人:NIKLEWICZ PAWEL GRZEGORZ; LAPCZYNSKI RADOSLAW MIECZYSLAW; PLUTA JANUSZ; OWCZAREK ARTUR; KAROLEWICZ BOZENA
    权利人:SILESIAN CATALYSTS SP Z O O
    摘要:The invention relates to a method for preparing N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine, a compound from the group of 2-aminopyrimidine derivatives, which is the precursor of active pharmaceutical ingredients, in particular imatinib. n The method of production of N-(2-methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine or other 2-pyrimidineamine lies in that 3-(dimethylamino)-1-(3-pyridyl)prop-2-en-1-one, after being mixed with 1-(2-methyl-5-nitrophenyl)-guanidine nitrate and an alkali hydroxide, preferably sodium hydroxide dissolved in a solvent in the form of dimethyl sulfoxide (DMSO), is subjected to coupling reaction under a pressure from 1 to 50 MPa in a rotating microwave field, with an absorbed microwave power volumetric density contained in the range from 1 W/cm 3 to 1 MW/cm 3 . The coupling process is preferably conducted at a temperature from 300 to 773K, wherein the volumetric density of microwave power absorbed by the reaction system under isothermal process conditions is controlled during the synthesis process. n In a variant of the method, the reagents are subjected to coupling reaction in a microwave reactor, in which the reaction vessel is placed in a container equipped with at least two microwave ports supplying microwave energy to the reagents positioned in the reaction vessel by means of electrodes that are isolated from the reagents by a dielectric layer and play the role of coupling elements.

    专利号:WO-2008024829-A2
    优先权日:2006-08-23
    标 题:Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00253-014-6003-1
    摘要:Fan J, Dong X, Zhang W, Zeng X, Li Y, Sun Y, Wang S, Wang Z, Gao H, Zhao W, Ju D. Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells. Applied Microbiology and Biotechnology. 2014 Sep 10;98(23):9763–75. doi: 10.1007/s00253-014-6003-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知